Estrogen receptor ligands affect mitochondrial activity in SH-SY5Y human neuroblastoma cells

Neuroreport. 2002 May 24;13(7):957-60. doi: 10.1097/00001756-200205240-00011.

Abstract

We have studied the pharmacological regulation of mitochondrial activity in a human neuroblastoma cell line. Cyclosporin A was found to directly alter mitochondrial membrane potential and to decrease mitochondrial permeability as measured using calcein. The estrogen receptor ligands tamoxifen, nafoxidine and clomiphene were identified as agents which affect mitochondrial membrane potential in a cyclosporin A-like manner. Also when mitochondrial permeability was measured using calcein, tamoxifen, nafoxidine and clomiphene were effective in inhibiting dye loss from mitochondria. Nafoxidine and cyclosporin A inhibit effects of mastoparan on SH-SY5Y mitochondria. These studies indicate that estrogen receptor ligands appear to affect mitochondria in a cyclosporin A-like manner in human neuroblastoma cells.

MeSH terms

  • Cyclosporine / pharmacology
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Intracellular Membranes / drug effects
  • Intracellular Membranes / metabolism
  • Ligands
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Mitochondria / physiology
  • Neuroblastoma / metabolism*
  • Permeability / drug effects
  • Receptors, Estrogen / antagonists & inhibitors
  • Receptors, Estrogen / metabolism*
  • Receptors, Estrogen / physiology
  • Selective Estrogen Receptor Modulators / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Enzyme Inhibitors
  • Ligands
  • Receptors, Estrogen
  • Selective Estrogen Receptor Modulators
  • Cyclosporine